Hypoxia‐inducible micro RNA ‐210 regulates the DIMT 1‐ IRF 4 oncogenic axis in multiple myeloma

Multiple myeloma ( MM ) is characterized by the accumulation of a population of malignant plasma cells within the bone marrow and its microenvironment. A hypoxic niche is located within the microenvironment, which causes myeloma cells to become quiescent, anti‐apoptotic, glycolytic, and immature. Ce...

Full description

Saved in:
Bibliographic Details
Published inCancer science Vol. 108; no. 4; pp. 641 - 652
Main Authors Ikeda, Sho, Kitadate, Akihiro, Abe, Fumito, Saitoh, Hirobumi, Michishita, Yoshihiro, Hatano, Yoshiaki, Kawabata, Yoshinari, Kitabayashi, Atsushi, Teshima, Kazuaki, Kume, Masaaki, Takahashi, Naoto, Tagawa, Hiroyuki
Format Journal Article
LanguageEnglish
Published 01.04.2017
Online AccessGet full text

Cover

Loading…
More Information
Summary:Multiple myeloma ( MM ) is characterized by the accumulation of a population of malignant plasma cells within the bone marrow and its microenvironment. A hypoxic niche is located within the microenvironment, which causes myeloma cells to become quiescent, anti‐apoptotic, glycolytic, and immature. Cell heterogeneity may be related to distinct gene expression profiles under hypoxic and normoxic conditions. During hypoxia, myeloma cells acquire these phenotypes by downregulating interferon regulatory factor 4 ( IRF 4), an essential transcription factor in myeloma oncogenesis. To identify essential micro RNA s and their targets regulated under hypoxic conditions, we undertook micro RNA and c DNA microarray analyses using hypoxia‐exposed primary MM samples and myeloma cell lines. Under hypoxia, only miR‐210 was highly upregulated and was accompanied by direct downregulation of an 18S r RNA base methyltransferase, DIMT 1. This inverse expression correlation was validated by quantitative RT ‐ PCR for primary MM samples. We further determined that DIMT 1 has an oncogenic potential as its knockdown reduced tumorigenicity of myeloma cells through regulation of IRF 4 expression. Notably, by analyzing gene expression omnibus datasets in the National Center for Biotechnology Information database, we found that DIMT 1 expression increased gradually with MM progression. In summary, by screening for targets of hypoxia‐inducible micro RNA ‐210, we identified DIMT 1 as a novel diagnostic marker and therapeutic target for all molecular subtypes of MM .
ISSN:1347-9032
1349-7006
DOI:10.1111/cas.13183